These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35429311)

  • 1. Individual and structural-level Correlates of Pre-exposure Prophylaxis (PrEP) lifetime and current use in a nationwide sample of young sexual and gender minorities.
    Fitch C; Haberer JE; Serrano PA; Muñoz A; French AL; Hosek SG
    AIDS Behav; 2022 Oct; 26(10):3365-3377. PubMed ID: 35429311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV care cascade and associated factors among men who have sex with men, transgender women, and genderqueer individuals in Zimbabwe: findings from a biobehavioural survey using respondent-driven sampling.
    Harris TG; Wu Y; Parmley LE; Musuka G; Mapingure MP; Chingombe I; Mugurungi O; Hakim A; Gozhora P; Miller SS; Lamb MR; Samba C; Rogers JH
    Lancet HIV; 2022 Mar; 9(3):e182-e201. PubMed ID: 35150606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis.
    Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN
    Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Preexposure Prophylaxis Practice among Urban Female Sex Workers in Northwest Ethiopia: Using Generalized Structural Equation Modeling.
    Asmare L; Goshu A; Alemu T; Gebeye E
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241302900. PubMed ID: 39632570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing event-driven HIV pre-exposure prophylaxis use among gay, bisexual and other men who have sex with men in Australia: results from behavioural surveillance 2019-2023.
    Chan C; Holt M; Smith AKJ; Broady TR; MacGibbon J; Mao L; Wilcock B; Rule J; Bavinton BR
    J Int AIDS Soc; 2024 Nov; 27(11):e26398. PubMed ID: 39581846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for Starting Daily, On-Demand, and Long-Acting Injectable HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in the United States (2021-2022): Nationwide Online Cross-Sectional Study.
    Islek D; Sanchez T; Glick JL; Jones J; Rawlings K; Sarkar S; Sullivan PS; Vannappagari V
    JMIR Public Health Surveill; 2024 Nov; 10():e62801. PubMed ID: 39536313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual and partnership characteristics associated with consistent condom use in a cohort of cisgender men who have sex with men and transgender women in Nigeria.
    Olawore O; Crowell TA; Ketende SC; Ramadhani HO; Liu H; Ake JA; Kokogho A; Adebajo S; Charurat ME; Nowak RG; Baral SD;
    BMC Public Health; 2021 Jun; 21(1):1277. PubMed ID: 34193101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of Persons Recently Infected with HIV-1 in Belgium: New Insights to Tailor Prevention Efforts.
    Vanden Bulcke C; Deblonde J; Necsoi C; Van Praet J; Van Cutsem E; Mertens L; Vanroye F; Stoffels K; Debaisieux L; Mortier V; Callens S; Verhofstede C
    AIDS Behav; 2024 Dec; 28(12):4167-4178. PubMed ID: 39287735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping Implementation Strategies to Address Barriers to Pre-Exposure Prophylaxis Use Among Women Through POWER Up (Pre-Exposure Prophylaxis Optimization Among Women to Enhance Retention and Uptake): Content Analysis.
    Johnson AK; Devlin SA; Pyra M; Etshokin E; Ducheny K; Friedman EE; Hirschhorn LR; Haider S; Ridgway JP
    JMIR Form Res; 2024 Nov; 8():e59800. PubMed ID: 39546769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM
    MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities of HIV risk and PrEP use among transgender women of color in South Florida.
    Holder CL; Perez-Gilbe HR; Fajardo FJ; Garcia S; Cyrus E
    J Natl Med Assoc; 2019 Dec; 111(6):625-632. PubMed ID: 31526532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment.
    Sullivan AK; Saunders J; Desai M; Cartier A; Mitchell HD; Jaffer S; Ogaz D; Chiavenna C; Charlett A; Diamente V; Golombek R; Manavi K; Priestley C; Waters LJ; Milinkovic A; McOwan A; Estcourt C; Sabin CA; Rodger A; Gold D; Gazzard BG; McCormack S; Gill ON;
    Lancet HIV; 2023 Dec; 10(12):e790-e806. PubMed ID: 38040478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual Identity Development and Social Ecological Facilitators and Barriers of PrEP Uptake and Adherence Among Latinx Men Who Have Sex with Men.
    Dillon FR; Ertl MM; Eklund AC; Westbrook J; Balek G; Algarin A; Martin J; Sánchez FJ; Ebersole R
    Arch Sex Behav; 2024 Mar; 53(3):1197-1211. PubMed ID: 38212437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early adopters of doxycycline as post-exposure prophylaxis to prevent bacterial sexually transmitted infections in a real-world clinical setting.
    Chan PA; Malyuta Y; Parent H; Tao J; Erbe M; Salhaney P; Maynard M; DeWitt W; Reisopoulos A; Nunn A
    Sex Transm Infect; 2024 Aug; 100(6):339-342. PubMed ID: 38821877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
    Smith J; Bansi-Matharu L; Cambiano V; Dimitrov D; Bershteyn A; van de Vijver D; Kripke K; Revill P; Boily MC; Meyer-Rath G; Taramusi I; Lundgren JD; van Oosterhout JJ; Kuritzkes D; Schaefer R; Siedner MJ; Schapiro J; Delany-Moretlwe S; Landovitz RJ; Flexner C; Jordan M; Venter F; Radebe M; Ripin D; Jenkins S; Resar D; Amole C; Shahmanesh M; Gupta RK; Raizes E; Johnson C; Inzaule S; Shafer R; Warren M; Stansfield S; Paredes R; Phillips AN;
    Lancet HIV; 2023 Apr; 10(4):e254-e265. PubMed ID: 36642087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.